Business Wire

GCCA

30.3.2022 08:02:04 CEST | Business Wire | Press release

Share
GCCA: Cement and Concrete Industry Launches Net Zero Accelerators Across the World – Including Focus on the ‘Global South’

The Global Cement and Concrete Association (GCCA) has today launched a series of Net Zero Accelerator initiatives to help national cement and concrete industries decarbonise in line with the GCCA’s 2050 Net Zero Global Industry Roadmap.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220329005500/en/

The first wave of Accelerators will launch in Egypt, which later this year will be the host country for COP27, as well as in India, Thailand and Colombia. These countries combined represent approximately 10% of global cement and concrete production. Concrete, a local and durable material, is fundamental to overcoming sustainable development challenges which many parts of the world are facing, such as population growth, increasing urbanisation and the need for more resilient infrastructure and communities in the face of a rapidly changing climate.

Globally, cement and concrete manufacture accounts for around 7% of CO2 emissions. The global plan to eliminate these emissions by 2050 requires all parts of the world to accelerate the reductions in CO2 emissions. The Accelerator program will identify the barriers to decarbonisation in target countries and recommend key actions. This includes encouraging government policies that can have an immediate impact, such as better recycling, the use of waste as an alternative to fossil fuels, and other circular economy practices. It will also include identifying lighthouse projects that can fully eliminate emissions over the next decades, such as carbon capture utilisation and storage technologies.

Thomas Guillot, GCCA Chief Executive, said: “Last year our industry made a breakthrough net zero global commitment. This is the next logical step as we move our focus from a global roadmap to driving decisive local action.

“Concrete will continue to be the world’s most used building material for decades to come, meaning global cooperation between governments and industry is crucial to ensuring net zero targets are met. Our Net Zero Accelerators will offer collaboration and support to a number of target countries to help them decarbonise and align with the global roadmap. I’m proud to launch the first phase of the Accelerator program to assist these nations in embracing greener technologies and work towards a more sustainable future together. I now call on more partners around the world to join us and be part of this movement.”

His Excellency, Dr Mahmoud Mohieldin, COP 27 UNFCCC High-Level Champion of Egypt, said: “Much of the infrastructure the world needs to overcome our major global challenges – such as alleviating poverty, the need for clean water and energy, and safe, affordable housing – is yet to be built.

“Cement and concrete will play a critical role in delivering a healthier, more resilient, zero carbon world as the industry moves to rapidly and fully decarbonise. As such, we are pleased to support the Net Zero Accelerator initiative, helping developing countries achieve their decarbonisation targets, as we work to support all industries and countries with their climate ambitions to help build a more sustainable future for all. The full and willing participation of a sector which accounts for 7-8% of global CO2 emissions is critical to contribute to the goal of the 2015 Paris Climate Change Agreement to limit global warming well below 2°C degrees and as close as possible to 1.5°C.”

The accelerator programme comprises three elements – i. net zero national roadmaps including emissions forecasts, reduction levers, policy needs and the industry commitment; ii. identification and funding exploration for large scale carbon cutting ‘Lighthouse’ Projects; and iii. policy dialogues with national governments to help accelerate the transition.

The GCCA is partnering with the cement and concrete industry on the ground and will work closely with policymakers, designers, and the construction sector to help overcome procurement and resourcing challenges, as well as demonstrate the business case for greener technologies to be used on a wider scale.

The Accelerators will help align Phase 1 countries’ cement and concrete industries with the GCCA’s 2050 Net Zero Roadmap , which marked the biggest global commitment by a heavy industry to decarbonise when it was launched last year. The Roadmap sets out a path to fully decarbonise by 2050, a target aligned with the Paris Agreement to limit global warming to 1.5°C. The roadmap actions between now and 2030, to reduce concrete related emissions by 25%, will prevent almost 5 billion tonnes of carbon from entering the atmosphere compared to a business-as-usual scenario.

Lighthouse Projects and a new tranche of phase two Accelerators will be announced later this year.

-ends-

Notes to editors:

About the GCCA:

Launched in January 2018, the Global Cement and Concrete Association (GCCA) is dedicated to developing and strengthening the sector’s contribution to sustainable construction. The GCCA aims to foster innovation throughout the construction value chain in collaboration with industry associations as well as architects, engineers, and innovators. In this way, the association demonstrates how concrete solutions can meet global construction challenges and sustainable development goals while showcasing responsible industrial leadership in the manufacture and use of cement and concrete. The GCCA is headquartered in London, England. It complements and supports the work done by associations at the national and regional levels.

The GCCA works with key a range of partners. It co-leads the Mission Possible Partnership’s Concrete Action for Climate initiate with the World Economic Forum. The GCCA is also an official accelerator for the Race to Zero.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye